Detalles de la búsqueda
1.
Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers.
Nature
; 603(7900): 335-342, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35236983
2.
Locally Recurrent Secretory Carcinoma of the Breast with NTRK3 Gene Fusion.
Oncologist
; 26(10): 818-824, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34176200
3.
Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA.
Cancer
; 124(10): 2115-2124, 2018 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29517810
4.
Actionable exomic incidental findings in 6503 participants: challenges of variant classification.
Genome Res
; 25(3): 305-15, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25637381
5.
Parents' Perspectives on Variants of Uncertain Significance from Chromosome Microarray Analysis.
J Genet Couns
; 25(1): 101-11, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25983052
6.
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC.
Cancer Res Commun
; 4(3): 786-795, 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38407352
7.
Molecular heterogeneity and co-altered genes in MET-amplified ALK-positive lung cancer: Implications for MET targeted therapy.
Lung Cancer
; 186: 107383, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37813016
8.
The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 after Progression on Rucaparib.
Clin Cancer Res
; 29(24): 5207-5216, 2023 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37486343
9.
Pan-Cancer Prevalence of Microsatellite Instability-High (MSI-H) Identified by Circulating Tumor DNA and Associated Real-World Clinical Outcomes.
JCO Precis Oncol
; 7: e2300118, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37769226
10.
Efficacy and Tolerability of ALK/MET Combinations in Patients With ALK-Rearranged Lung Cancer With Acquired MET Amplification: A Retrospective Analysis.
JTO Clin Res Rep
; 4(8): 100534, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37533439
11.
Use of on-therapy ctDNA monitoring in a patient with KIF5B-RET fusion positive advanced non-small cell lung cancer: a case report.
Transl Lung Cancer Res
; 11(1): 111-116, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35242632
12.
Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer.
Nat Cancer
; 3(6): 710-722, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35726063
13.
The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer.
Ther Adv Med Oncol
; 14: 17588359221112696, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35923926
14.
Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling of cell-free DNA.
Front Oncol
; 12: 966534, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36185208
15.
Olaparib in hormone receptor-positive, HER2-negative metastatic breast cancer with a somatic BRCA2 mutation.
Ther Adv Med Oncol
; 13: 17588359211006962, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33868464
16.
Corrigendum: Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic.
Front Oncol
; 11: 674782, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34026652
17.
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy.
JCO Precis Oncol
; 52021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34095713
18.
Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK Reactivation.
Cancer Discov
; 11(8): 1913-1922, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33824136
19.
The dynamic landscape of BRCA1 reversion mutations from indel to SNV in a patient with ovarian cancer treated with PARP-inhibitors and immunotherapy.
Heliyon
; 6(5): e03841, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32420470
20.
Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot Study.
Eur Urol Oncol
; 3(5): 695-699, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31412004